{
    "code": 0,
    "data": [
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call - Q3 FY26",
            "news_id": "32b7796d-f0af-4338-843a-ca0aca794931",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=735f829e-c6b6-4fea-ba4f-01770bcd3566.pdf",
            "news_date": "2026-02-10 18:00:25",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call - Q3 FY26",
            "news_id": "c6462646-8287-494c-8bda-e46fae052447",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a546f43f-c112-4188-b852-4c7458bd922a.pdf",
            "news_date": "2026-02-04 18:35:15",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Consolidated And Standalone) For The Quarter And Nine Months Ended December 31 2025.",
            "news_body": "Unaudited Financial Results (Consolidated and Standalone) for the quarter and nine months ended December 31 2025",
            "news_id": "55cf2acf-2d17-41a6-a509-7eddfdd390c6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9b03194-f3ef-4604-827f-b9a8a963fd5d.pdf",
            "news_date": "2026-02-04 13:40:47",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Investor Conferences to be attended by officials of the Company on November 19 2025 and November 20 2025",
            "news_id": "d4dddc56-2110-45cc-aa41-a59015c55eb9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d68fbde8-815b-4168-9eed-97c965b6ad1a.pdf",
            "news_date": "2025-11-19 11:07:49",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call - Q2 FY26",
            "news_id": "eaeb6386-0ce4-4515-9e7e-41383aa11a7e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=615067f0-f75b-4b11-918e-e8edfd924ae8.pdf",
            "news_date": "2025-11-17 16:36:50",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call - Q2 FY26",
            "news_id": "322cf092-07d6-46f2-bd76-f0a26846495a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11e0261d-7369-44fe-be09-84088a2c6bbf.pdf",
            "news_date": "2025-11-11 17:06:46",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half-Year Ended September 30 2025",
            "news_body": "Unaudited Financial Results (Consolidated and Standalone) for the quarter and half-year ended September 30 2025",
            "news_id": "87183aee-4332-454e-a410-2ae5d1cf717b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d0d8415-d775-41fe-aae8-92053a1ecac1.pdf",
            "news_date": "2025-11-11 13:35:29",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call - Q1 FY26 held on August 07 2025 at 3.30 pm (IST)",
            "news_id": "9b70a444-cb7c-4a63-a7bb-dbac6fc13a05",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4ed26ca-76ef-422a-a01e-753ea63ac0ac.pdf",
            "news_date": "2025-08-13 15:56:17",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call - Q1 FY26",
            "news_id": "5de69580-b23b-4f3b-b65f-abf969c0af48",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=241e7714-1290-4057-aa22-7a33144873d2.pdf",
            "news_date": "2025-08-07 21:31:25",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On August 07 2025 To Approve The Unaudited Financial Results (Consolidated And Standalone) For The Quarter Ended June 30 2025",
            "news_body": "Outcome of the Board Meeting held on August 07 2025 to approve the Unaudited Financial Results (Consolidated and Standalone) for the quarter ended June 30 2025",
            "news_id": "4e9a8815-f5e8-48dc-8e89-2e1805faa4e2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a1385be-7335-4286-b3ed-f75dcf89f7e2.pdf",
            "news_date": "2025-08-07 13:42:10",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The transcript of Earnings Call for Q4 FY 25 held on May 22 2025 at 3:30 P.M. (IST)",
            "news_id": "1bcd9694-5993-41ef-8c77-d5cce851f6a4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b44febc-6ee7-4bd6-88cb-46a4faedbb39.pdf",
            "news_date": "2025-05-28 18:12:02",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call - Q4 FY25",
            "news_id": "d5cc0d50-81b5-4a98-a3d7-834ada151ba1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f17d4c1a-498c-4030-8ca8-09a9505b8448.pdf",
            "news_date": "2025-05-22 18:24:14",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31 2025",
            "news_body": "Audited Financial Results for the quarter and year ended March 31 2025",
            "news_id": "d2a3b41c-5baa-48ff-a2be-f6d2ddd7c5ab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=309bfcf3-0319-4369-8c8e-8e5cd874ed98.pdf",
            "news_date": "2025-05-22 14:49:20",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The transcript of the Earnings Call for the Q3 FY25 held on February 06 2025 at 5:30 p.m. (IST)",
            "news_id": "1a9458a0-325f-4cd4-a4e0-46070ebbfd3c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e7ff1a5-c6ae-490a-a58a-d9d512129ebd.pdf",
            "news_date": "2025-02-11 18:36:16",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Consolidated And Standalone) For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "Unaudited Financial Results (Consolidated & Standalone) For the quarter and nine months ended December 31 2024",
            "news_id": "d6a5055e-3308-4dc4-b1da-a7e11ca0a368",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d46a6a1e-f799-45eb-bb40-a9679165f9d8.pdf",
            "news_date": "2025-02-06 15:04:10",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated October 29, 2024, please find enclosed the transcript of the Earnings Call for the Q2 FY25, held on Thursday, November 07, 2024, at 6.30 p.m. (IST).",
            "news_id": "0d0177d9-1f3b-4465-830a-415c1c8567ca",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6265d94f-e2f0-44d4-a79e-83887697f462.pdf",
            "news_date": "2024-11-13 17:22:07",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated October 29, 2024 regarding earnings call, the audio recording of the call held yesterday i.e. on November 07, 2024, is available on our website. The said audio recording can be accessed through the below web address:https://www.emcure.com/wp-content/uploads/2024/11/EMC0220241107156104.mp3",
            "news_id": "7a2dceca-4b75-44aa-9acf-5f9aa16b9245",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14d4f1d4-b3e2-4e0a-8f9c-2945675bf3f6.pdf",
            "news_date": "2024-11-08 17:38:06",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024",
            "news_body": "Outcome of Board Meeting held on November 7, 2024",
            "news_id": "b5def008-639e-40bd-9d8e-3c1430716b31",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=022ed7d1-8856-41da-be40-18822b7dcd79.pdf",
            "news_date": "2024-11-07 15:41:31",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform that the Earnings Call for Investors/ Analysts will be held on Thursday, November 07, 2024 at 6:30 p.m. (IST) to discuss the Company''s unaudited financial results (standalone and consolidated) and performance for the quarter ended September 30, 2024.The details of the aforesaid earnings call for Investors/Analysts is enclosed.The transcript and the audio recording of the Earnings Call will be made available on the Company's website and will be intimated accordingly.",
            "news_id": "ce41d401-b363-4751-8948-21a176dd90eb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2cebbdd-4a59-40ba-9a7c-5fac707f1f34.pdf",
            "news_date": "2024-10-29 19:03:04",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and further to our intimation dated August 8, 2024, please find enclosed the transcript of the Earnings Call for the Q1 FY25, held on Wednesday, August 14, 2024 at 8.30 a.m. (IST).",
            "news_id": "5855083c-b694-4d66-94f1-2f0719626a3f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=359c6789-0a69-4e2d-a8fb-5bd840334030.pdf",
            "news_date": "2024-08-19 16:52:13",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated August 8, 2024, regarding earnings call, the audio recording of the call held today is available on our website.",
            "news_id": "93527dd9-d0b7-4e93-81d1-d36620d1d714",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c481e23-913f-4cf7-a784-2b599197141e.pdf",
            "news_date": "2024-08-14 17:06:20",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On August 13, 2024",
            "news_body": "Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Unaudited Financial Results for the quarter ended June 30, 2024, along with the Limited Review Reports on the aforesaid results as issued by the B S R & Co. LLP, Chartered Accountants, Auditors of the Company, enclosed as Annexure A.Press Release outlining key updates on the aforesaid results are enclosed as Annexure B.",
            "news_id": "634b5690-b948-4723-b6c0-09ae5f2cab58",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5fffcca-b928-42b4-82d0-64a9a7dc519f.pdf",
            "news_date": "2024-08-13 21:13:50",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}